Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 2/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | SLC25A20 | O43772 | 3/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5356676 | 0.89 | ALDH1A1 (0.39) | CA4TSHR | |
| SCHEMBL28482797 | 0.86 | NAAA (0.45) | TSHRGPR84 | |
| SCHEMBL27875072 | 0.83 | NAAA (0.41) | NFKB1SLC25A20TP53CYP2D6TSHR | |
| Malic Acid SCHEMBL511412 | 0.83 | CA4 (0.59) | CA4NFKB1CA1GPR84 | |
| SCHEMBL5360765 | 0.83 | CA4 (0.46) | CA4MEN1CYP2C9CYP2C19KMT2A | |
| Potassium Ion SCHEMBL23607609 | 0.82 | CA4 (0.50) | CA4MEN1CYP2C19KMT2AHSD17B10 | |
| SCHEMBL31078478 | 0.82 | CA4 (0.50) | CA4MEN1CYP2C19KMT2AHSD17B10 | |
| SCHEMBL21496190 | 0.81 | NAAA (0.36) | NFKB1CA1GPR84 | |
| SCHEMBL27951108 | 0.80 | ALDH1A1 (0.44) | TSHRMEN1CYP3A4CYP2C9CYP2C19 | |
| Malic Acid SCHEMBL749592 | 0.77 | CA4 (0.55) | CA4NFKB1CA1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090098384-A1 | CURABLE ORGANOPOLYSILOXANE COMPOSITION AND ANTIFOULING COMPOSITE COATING FILM | CHUGOKU MARINE PAINTS, LTD. (JP) | 2009-04-16 | — | — | US | claimed |
| EP-1990366-A1 | CURABLE ORGANOPOLYSILOXANE COMPOSITION AND ANTIFOULING COMPOSITE COATING FILM | CHUGOKU MARINE PAINTS, LTD. (JP) | 2008-11-12 | — | — | EP | claimed |
| WO-2024195656-A1 | ANTI-FOULING COATING MATERIAL COMPOSITION | 中国塗料株式会社 | 2024-09-26 | — | — | WO | disclosed |
| US-9752036-B2 | Curable organopolysiloxane antifouling composite coating film, and antifouling substrate coated with the same | CHUGOKU MARINE PAINTS, LTD. (JP) | 2017-09-05 | — | — | US | disclosed |
| US-20150291808-A1 | CURABLE ORGANOPOLYSILOXANE ANTIFOULING COMPOSITE COATING FILM, AND ANTIFOULING SUBSTRATE COATED WITH THE SAME | CHUGOKU MARINE PAINTS, LTD. (JP) | 2015-10-15 | — | — | US | disclosed |
| EP-2921297-A1 | CURABLE ORGANOPOLYSILOXANE ANTI-FOULING COMPOSITE COATING, AND ANTI-FOULING SUBSTRATE COATED WITH THE COMPOSITE COATING | Chugoku Marine Paints, Ltd. (JP) | 2015-09-23 | — | — | EP | disclosed |
| US-20090098384-A1 | CURABLE ORGANOPOLYSILOXANE COMPOSITION AND ANTIFOULING COMPOSITE COATING FILM | CHUGOKU MARINE PAINTS, LTD. (JP) | 2009-04-16 | — | — | US | disclosed |
| EP-1990366-A1 | CURABLE ORGANOPOLYSILOXANE COMPOSITION AND ANTIFOULING COMPOSITE COATING FILM | CHUGOKU MARINE PAINTS, LTD. (JP) | 2008-11-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090098384-A1 | CURABLE ORGANOPOLYSILOXANE COMPOSITION AND ANTIFOULING COMPOSITE COATING FILM | FUCA1, CELA1, IDUA | CA4 516/4885NFKB1 4117/4885CA1 480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.